SP
AUTL

Syncona Portfolio’s Autolus Therapeutics AUTL Stock Holding History

Syncona Portfolio’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23M Hold
16,640,720
– – 89.34% 1
2025
Q4 		$33.1M Hold
16,640,720
– – 96.48% 1
2025
Q3 		$27.1M Hold
16,640,720
– – 97.82% 1
2025
Q2 		$37.9M Hold
16,640,720
– – 98.24% 1
2025
Q1 		$25.8M Hold
16,640,720
– – 97.81% 1
2024
Q4 		$39.1M Sell
16,640,720
-1,913,904
-10% -$6.47M 73.83% 1
2024
Q3 		$67.4M Sell
18,554,624
-2,792,205
-13% -$11.1M 83.42% 1
2024
Q2 		$74.3M Hold
21,346,829
– – 86.51% 1
2024
Q1 		$136M Hold
21,346,829
– – 90.76% 1
2023
Q4 		$137M Hold
21,346,829
– – 87.15% 1
2023
Q3 		$49.7M Hold
21,346,829
– – 74.11% 1
2023
Q2 		$50.8M Hold
21,346,829
– – 76.58% 1
2023
Q1 		$39.3M Hold
21,346,829
– – 63.85% 1
2022
Q4 		$40.6M Buy
21,346,829
+14,000,000
+191% +$35.4M 64.38% 1
2022
Q3 		$15.7M Hold
7,346,829
– – 27.32% 2
2022
Q2 		$20.8M Hold
7,346,829
– – 29.54% 2
2022
Q1 		$38.1M Hold
7,346,829
– – 36.42% 2
2021
Q4 		$38.1M Buy
+7,346,829
New +$44.1M 36.42% 2

Other funds holding AUTL

MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Syncona Portfolio's AUTL Position: Q1 2026 in Review

Syncona Portfolio held its Autolus Therapeutics (AUTL) position steady in Q1 2026 at 16,640,720 shares worth $23M. The position accounts for 89.34% of the portfolio, ranked #1.

Syncona Portfolio first reported a position in AUTL in Q4 2021 and has held it in 18 quarters since. The position peaked at $137M in Q4 2023. 84 funds tracked by Wall St. Rank hold AUTL as of Q1 2026.

  • Syncona Portfolio held 16,640,720 shares of Autolus Therapeutics worth $23M as of Q1 2026.
  • Syncona Portfolio left its Autolus Therapeutics share count unchanged in Q1 2026.
  • Autolus Therapeutics made up 89.34% of Syncona Portfolio's portfolio in Q1 2026, its #1 holding.
  • Syncona Portfolio first reported a position in Autolus Therapeutics in Q4 2021 and has held it in 18 quarters since.
  • Syncona Portfolio's Autolus Therapeutics position peaked at $137M in Q4 2023.
  • 84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q1 2026.

Based on Syncona Portfolio's 13F filing for Q1 2026, filed 14 May 2026.